ALFA FinderBSE filing, NSE: NIRLON. Summary written from the filing by ALFA Finder's alert engine.
Nirlon Ltd: key numbers
- Share price
- ₹635.85
- Market cap
- ₹5,730 Cr
- Revenue (annual)
- ₹669.2 Cr
- Net profit (annual)
- ₹346.0 Cr
- P/E (TTM)
- 20.4×Sector 38.2×
- Promoter holding
- 67.64%-0.01% QoQ
- FII holding
- 4.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nirlon Ltd
All →Nirlon Earnings Call Transcript: Key Takeaways
Q2 total income rose 3% YoY to ₹174 Cr, with EBITDA of ₹137 Cr at a 78.4% margin. Management deflected on cash deployment, dividends, NKP vacancy and the NH sale. No new numeric guidance was given.
Nirlon Q2 FY27 Results: Net Profit ₹71.9 Cr, Down 51.3% YoY
Nirlon Ltd reported revenue from operations of ₹169.1 Cr (+2.3% YoY) and net profit of ₹71.9 Cr (-51.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹71.9 Cr · -51.3% YoY
Nirlon Board Meeting Outcome
Nirlon Ltd's board approved a modification to its Dividend Distribution Policy on November 2, 2026. This is a routine governance update with no dividend declared or cash impact.
Nirlon Investor Presentation: Key Takeaways
Q2 FY27 total income ₹1,741 Mn (+3.1% YoY), EBITDA ₹1,365 Mn (78.40% margin), PAT ₹719 Mn. PAT fell 51.3% YoY against a prior-year ₹69.50 Cr one-time tax reversal.
Nirlon Other Announcement
Nirlon Ltd has submitted its quarterly shareholding pattern pursuant to Regulation 31(1)(b) of SEBI (LODR) Regulations, 2015, for the quarter ending September 30, 2026.
Nirlon Capital Structure Change
BSREP IV FPI Two Holdings (DIFC) Limited acquired 23,25,000 equity shares (2.58%) of Nirlon Ltd from InRe Fund II via an inter-se off-market transfer.
Other annual report announcements
All →Generic Engineering Construction and Projects Annual Report
Generic Engineering filed its FY2025-26 Annual Report ahead of its 32nd AGM on 30 November 2026. The filing covers board changes and a planned bank-funded EPC expansion.
Vineet Laboratories Annual Report
Vineet Laboratories filed its FY 2025-26 Annual Report, which marks its turnaround and recapitalisation year. The AGM is scheduled for 30 November 2026.
Indrayani Biotech Annual Report
Indrayani Biotech has filed its 34th Annual Report for FY2025-26, containing the AGM notice for 30 November 2026 by VC/OAVM. The chairman notes a Rights Issue was initiated in October 2026 to raise capital.
ESDS Software Solution Annual Report
ESDS Software Solution submitted its FY2025-26 Annual Report along with the AGM notice. The AGM is on 30 November 2026 via VC/OAVM, with remote e-voting.
The Orissa Minerals Development Company Annual Report
Orissa Minerals Development Company filed its FY 2025-26 Annual Report and 108th AGM notice, with the AGM set for 30 November 2026. The filing is a Regulation 34 intimation with no transaction or financial event.
Viksit Engineering Annual Report
Viksit Engineering filed its 44th Annual Report for FY 2025-26 with BSE. The report includes notice of the AGM on 30 November 2026.